AMWC2026:GaldermaShowcasesCategoryleadingInnovationWithaComprehensivePortfolioandHolistic,FuturefocusedAestheticStrategies
===2026/3/17 16:28:11===
;23(4):285–288. doi: 10.36849/JDD.7791.
Galderma. Data on File. MA-46589.
Vleggaar D, et al. Consensus recommendations on the use of injectable poly-L-lactic-acid for facial and nonfacial volumization. J Drugs Dermatol. 2014;13(4 Suppl):s44–s51.
Widgegrow J, et al. A randomized, comparative study describing the gene signatures of poly-l-lactic acid (PLLA-SCA) and Calcium Hydroxyapatite (CaHA) in the treatment of nasolabial folds. Poster presented at IMCAS World Congress; February 1-3, 2024. Paris, France.
Duracinsky M, et al. Safety of poly-L-lactic acid (New-Fill®) in the treatment of facial lipoatrophy: a large observational study among HIV-positive patients.BMC Infect Dis. 2014;14(474). doi: 10.1186/1471-2334-14-474.
Zhang S and Duan E. Fighting against Skin Aging: The Way from Bench to Bedside.Cell Transplant. 2018;27(5):729–738. doi: 10.1177/0963689717725755.
Shuster S, et al. The influen
=*=*=*=*=*=
当前为第14/20页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页